Summary
This narrative review synthesises evidence on microRNA involvement in osteoarthritis pathogenesis, evaluating their potential utility as non-invasive biomarkers for disease detection and as targets for therapeutic intervention. The authors examine how dysregulated miRNA expression patterns contribute to cartilage degradation and inflammatory processes characteristic of OA, and discuss methodological considerations for miRNA detection in clinical settings. The review reflects 2016-era understanding of miRNA biology in joint disease and emerging translational opportunities.
UK applicability
Findings are relevant to UK clinical practice and rheumatology research, particularly for development of improved diagnostic tools and disease-modifying therapies for OA. However, the translational pathway from biomarker discovery to clinical implementation in the NHS remains uncertain and would require further health economic evaluation.
Key measures
Literature synthesis on miRNA expression patterns in OA; miRNA detection methodologies; miRNA-targeted therapeutic approaches
Outcomes reported
The study examined the role of microRNAs (miRNAs) in osteoarthritis (OA) aetiology, their potential as diagnostic and prognostic biomarkers, and their therapeutic applications in OA management.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.